Sorafenib
CAS 284461-73-0
Em Estoque
Sorafenib
Cat. No. STUB-API-SORAFENIBCAS 284461-73-0Em Estoque
Dados Técnicos
Cat. No.STUB-API-SORAFENIB
CAS284461-73-0
Fórmula Mol.C21H16ClF3N4O3
Peso Mol.464.831 g/mol
IUPAC4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
SMILESCNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
InChIInChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)
Chave InChIMLDQJTXFUGDVEO-UHFFFAOYSA-N
Pureza—
Descrição
Visão geral
Sorofeni is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma
A Anant Labs fabrica e fornece impurezas de Sorafenib de alta qualidade para o mercado global. Nossas impurezas EP de Sorafenib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
Sorafenib284461-73-0BAY 43-9006sorafenibum4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamideDTXSID7041128BAY-43-9006N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
